MX2015016603A - Composiciones de corticosteroides. - Google Patents

Composiciones de corticosteroides.

Info

Publication number
MX2015016603A
MX2015016603A MX2015016603A MX2015016603A MX2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A
Authority
MX
Mexico
Prior art keywords
corticosteroid compositions
compositions
corticosteroid
making
methods
Prior art date
Application number
MX2015016603A
Other languages
English (en)
Inventor
Robert Lathrop
David Wade Osborne
Original Assignee
Tolmar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tolmar Inc filed Critical Tolmar Inc
Publication of MX2015016603A publication Critical patent/MX2015016603A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

La presente exposición se refiere en general a composiciones farmacéuticas de corticosteroides y a métodos para fabricarlas.
MX2015016603A 2013-06-03 2014-06-02 Composiciones de corticosteroides. MX2015016603A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361830531P 2013-06-03 2013-06-03
PCT/US2014/040560 WO2014197398A1 (en) 2013-06-03 2014-06-02 Corticosteroid compositions

Publications (1)

Publication Number Publication Date
MX2015016603A true MX2015016603A (es) 2016-07-28

Family

ID=51014660

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016603A MX2015016603A (es) 2013-06-03 2014-06-02 Composiciones de corticosteroides.

Country Status (9)

Country Link
EP (1) EP3003272A1 (es)
JP (1) JP2016520656A (es)
CN (1) CN105263474A (es)
AR (1) AR096459A1 (es)
AU (1) AU2014275195A1 (es)
CA (1) CA2912873A1 (es)
HK (1) HK1223300A1 (es)
MX (1) MX2015016603A (es)
WO (1) WO2014197398A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3141246A1 (en) 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
ITUB20153460A1 (it) * 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico
AU2018374029B2 (en) * 2017-11-27 2024-01-11 Umecrine Cognition Ab Pharmaceutical formulation of 3a-ethynyl-3B-hydroxyandrostan-17-one oxime

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
JP3471840B2 (ja) * 1993-03-04 2003-12-02 日本ワイスレダリー株式会社 外用剤
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
GB9618964D0 (en) * 1996-09-11 1996-10-23 Tillotts Pharma Ag Oral composition
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
CA2376850C (en) * 1999-06-25 2009-11-17 Durham Pharmaceuticals Ltd. Topical formulations comprising skin penetration agents and the use thereof
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
WO2005004843A1 (en) * 2003-07-07 2005-01-20 Nares Ab Microemulsions and its use for preventing airway diseases
CA2563609C (en) * 2004-04-22 2012-11-06 Duocort Ab Pharmaceutical compositions for acute glucocorticoid therapy
BRPI0518853A2 (pt) * 2004-12-09 2008-12-09 Bayer Healthcare Ag estabilizaÇço de Ésteres de glicocorticàides com Ácidos
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
GB2445539A (en) * 2006-12-29 2008-07-16 Ardana Bioscience Ltd Bigel composition
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
SG185521A1 (en) * 2010-06-11 2012-12-28 Leo Pharma As A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂

Also Published As

Publication number Publication date
WO2014197398A1 (en) 2014-12-11
CN105263474A (zh) 2016-01-20
AR096459A1 (es) 2015-12-30
EP3003272A1 (en) 2016-04-13
JP2016520656A (ja) 2016-07-14
CA2912873A1 (en) 2014-12-11
AU2014275195A1 (en) 2015-12-10
HK1223300A1 (zh) 2017-07-28

Similar Documents

Publication Publication Date Title
PH12016501763A1 (en) Multispecific antibodies
AU2016202480A1 (en) Seed-origin endophyte populations, compositions, and methods of use
IL243752B (en) Multispecific antibodies, preparations containing them and their uses
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
EP3102670A4 (en) Systems, methods, and compositions relating to combiomics
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
EP3082819A4 (en) Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX2016008448A (es) Conjugados de var2csa-farmaco.
TN2015000411A1 (en) Ceftolozane antibiotic compositions
EP3068500A4 (en) Fertilizer compositions and methods of making and using the same
IN2013MU03641A (es)
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
PL2988764T3 (pl) Kompozycje przeciwłupieżowe i sposoby ich zastosowania
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
EP3071214A4 (en) Salacia compositions, methods of treatment by their administration, and methods of their preparation
WO2014107596A8 (en) Compositions and methods for polynucleotide transfection
MX2015016603A (es) Composiciones de corticosteroides.
WO2014146111A3 (en) Analgesic compounds and methods of use
EP3089745A4 (en) Compounds, compositions, and methods for the treatment of cancers
IN2014DN06617A (es)
EP3057972A4 (en) Novel compositions, uses and methods for their preparation